SHERRY LEROY: Open Payments
NPI 1548869142 · PENSACOLA, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$777 in 34 payments from 19 companies in 2025. Trend: 2023 $1,187 · 2024 $551 · 2025 $777
Food & beverage: $777
| Company | Payments | Amount |
|---|---|---|
| E.R. Squibb & Sons, L.L.C. | 5 | $157 |
| Janssen Biotech, Inc. | 4 | $82 |
| ABBVIE INC. | 3 | $63 |
| Eisai Inc. | 3 | $61 |
| Novartis Pharmaceuticals Corporation | 3 | $53 |
| Daiichi Sankyo Inc. | 2 | $45 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $40 |
| AstraZeneca Pharmaceuticals LP | 2 | $35 |
| SERVIER PHARMACEUTICALS LLC | 1 | $28 |
| ARRAY BIOPHARMA INC | 1 | $25 |
Products named: OPDIVO, Lenvima, PLUVICTO, DATROWAY, ICLUSIG, Voranigo, BRAFTOVI, LIBTAYO.
Industry payments across FL — which companies pay providers there.
